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Purpose or Objective: High dose lung-sparing pleural 
radiotherapy for malignant pleural mesothelioma (MPM) is 
difficult. Accurate target delineation is critical. The optimal 
imaging modality to define radiotherapy target volumes has 
not been studied in depth. This is the aim of the present 
study.  
 
Material and Methods: Twelve consecutive patients with a 
histopathological diagnosis of stage I-IV MPM (6 left-sided and 
6 right-sided) were included. CT scans with IV contrast, 18F-
FDG PET/CT scans and MRI scans (post-contrast T1-weighted, 
T2 and diffusion-weighted images [DWI]) were obtained and 
downloaded from the institutional database onto a 
standalone image fusion workstation (MIM Software Inc., 
Cleveland, OH, USA) for image registration and contouring. 
CT scans were rigidly co-registered with 18FDG-CT-PET, with 
MRI scans and with DWI scans. Four sets of pleural GTVs were 
defined: 1) a CT-based GTV (GTVCT); 2)a PET/CT-based GTV 
(GTVCT+PET/CT); 3) a T1/T2-weighted MRI-based GTV 
(GTVCT+MRI); 4) a DWI-based GTV (GTVCT+DWI). Only the 
pleural tumor was contoured; mediastinal nodes were 
excluded. “Quantitative” and “qualitative” (visual) 
evaluation of the volumes was performed. 
 
Results: Compared to CT-based GTV definition, PET/CT 
identified additional tumour sites in 12/16 patients. 
Compared to either CT or PET/CT, MRI and DWI identified 
additional tumour sites in 15/16 patients. Mean GTVCT, 
GTVCT+PET/CT, GTVCT+MRI and GTVCT+DWI (+ standard 
deviation [SD]) were respectively 630.1 mL (+302.81), 640.23 
(+302.83), 660.8 (+290.8) and 655.2 mL(+290.7). Mean 
Jaccard index was lower in MRI-based contours versus all the 
others. 
 
Conclusion: To the best of our knowledge, this is the first 
study showing that the integration of MRI into the target 
volume definition in hemithoracic radiotherapy in MPM may 
allow to improve the accuracy of target delineation and 
reduce the likelihood of geographical misses.  
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Purpose or Objective: Texture and shape metrics are 
increasingly used for oncological applications such as the 
prediction of response to therapy. Commercial and freely 
available software tools have been used to publish significant 
results. However, it is unclear if these tools provide matched 
or even similar values, which is crucial when comparing such 
studies and drawing conclusions affecting patient 
management. In this work, we benchmark texture analysis 
software for PET in oesophageal cancer. 
 
Material and Methods: PET-STAT, a texture analysis tool 
written in the Matlab-based open source software CERR, was 
benchmarked against the open source software CGITA and 
the Radiomics package, on oesophageal cancer PET-CT scans. 
The PET scans and tumour outlines in DICOM format were 
processed on-site with PET-STAT and CGITA and remotely for 
Radiomics. Image resampling in PET-STAT matched the 
number of discrete intensities used in CGITA, where it was 
fixed, and in Radiomics, where the image bin width was set 
to 0.5 SUV. Texture and shape metrics present in PET-STAT 
and Radiomics or CGITA were matched by their mathematical 
description. The metrics calculated were Maximum, Mean 
intensity, SUVpeak, Volume, Total Lesion Glycolysis; 
histogram-based Standard Deviation, Skewness, Kurtosis, 
Entropy (HEp) and Energy; grey level cooccurrence matrix 
(GLCM)-based Entropy, Homogeneity and Dissimilarity; 
Coarseness (C); grey level size-zone-based Intensity 
Variability, Large Area Emphasis and Zone Percentage, and 
shape metrics Maximum Diameter, Compactness, Sphericity, 
Spherical disproportion. No C was found in Radiomics, no 
shape metrics nor HEp were found in CGITA. 
 
Results: Differences up to 7% in volume were observed 
between PET-STAT and CGITA, which disappeared when using 
data loaded from CERR, were due to different interpretation 
of the DICOM images and outline data. Errors of 7% in volume 
in one case compared with Radiomics may be due to different 
RTSTRUCT export or import in the study workflow. SUVpeak 
was up to 12% different between software packages due to 
different hard coded resampling of the PET image or kernel 
sizes used. Differences of up to 44% were observed in the 
calculation of shape metrics between Radiomics and PET-
STAT. This was due to differences in the triangulation 
technique used to calculate the contour surface area. 
Furthermore, differences of up to 30% across the cases 
considered, were found to be due to different equations used 
for resampling the image to discrete intensities, as well as 




Conclusion: Our benchmarking work on oesophageal cancer 
PET imaging reported a number of non trivial differences in 
texture and shape metric values when using different 
software packages. This highlights the importance of 
commissioning and validating texture analysis tools and 
recommends that detailed descriptions of the metric and 
software implementation are available.  
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Purpose or Objective: Biologically guided radiotherapy 
needs an understanding of how different functional imaging 
techniques link together. We analyse three functional 
imaging techniques that can be useful to characterize tumour 
behaviour: DWMRI, DCEMRI and PET/CT with FDG. 
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Material and Methods: An oropharynx cancer patient 
included in the ARTFIBIO project with a swollen node was 
selected. The pre-treatment imaging protocol was: MRI 
(DWMRI, DCEMRI) and PET/CT with FDG. Geometric distortion 
of DWMRI was corrected using the reversed gradient method 
(RGM) and the SPM8 software. DCEMRI analyses were 
performed using Dynamika® v4.0 
(www.imageanalysis.org.uk). All the datasets were registered 
using ARTFIBio tools. 
The parameters for classifying subvolumes were (Figure A): 
Initial Rate Enhancement (IRE) from DCEMRI, that measures 
the initial slope of gadolinium concentration and related to 
vascularization, Apparent Diffusion Coefficient (ADC) from 
DWMRI, previously corrected by the RGM, related to tumour 
density, and SUV from PET/CT with FDG. Thus, three 
subvolumes have been delimited: node, hypoxic volume (low 
IRE) and necrotic volume (red region in DWMRI b0, high ADC, 
very low IRE). 
 
Results: We have analysed the relationship between the 
three selected parameters (ADC, IRE and SUV) for the whole 
node and for the badly vascularized region excluding the 
necrotic region. When we considered the whole node (Figure 
B), we observe a complex relationship between these three 
parameters, but when we only consider the badly 
vascularized region (low IRE, low ADC), we observe a clear 
relationship between these parameters, that suggest that 
vascularization quantified by IRE must be related to 
oxygenation, as lowest vascularized dots (blue dots, figure 
C), correspond to high SUV for the same ADC, indicating an 





Conclusion: Several functional imaging techniques can be 
required to customize treatment, but an appropriate 
registration process must be applied. ADC maps can be used 
for tumour cell quantification, but distortion correction 
algorithm must be previously applied, RGM looks quite 
suitable. Oxygenation process can be estimated from DCEMRI 
in head and neck cancer, as vascularization is related to 
oxygenation in these cancers, and as our results suggest. 
PET/CT and MRI studies provide information about 
malignancy grade of the tumour, considering glucose 
metabolism, tumour cell density (from ADC maps) and 
oxygenation (DCEMRI).  
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Purpose or Objective: Identification of outcome predictive 
factors at an early stage of radiation therapy allows for 
adaptation and individualisation. Such predictive factors are 
crucial for advanced head and neck (H&N) cancer patients 
since the treatment failure is often caused by poor loco-
regional control. An early treatment adaptation would allow 
a dose escalation in the most radioresistant tumour regions. 
The aim of this study was to early identify sub-regions in H&N 
tumours non-responding to the treatment. This was achieved 
by applying a previously developed method using [18F]-
fluorodeoxy-D-glucose positron emission tomography (FDG 
PET) to evaluate the early responsiveness of lung tumours. 
 
Material and Methods: Thirteen patients with advanced H&N 
cancer were imaged with FDG PET before the start and 
during the second week of concurrent chemoradiotherapy 
(after about 19 Gy of delivered dose to the primary gross 
tumour volume, GTVprim). The acquired PET images were co-
registered to the planning CT and a systematic analysis was 
performed to calculate an operational parameter at voxel 
level, the effective radiosensitivity αeff which accounts for 
the accumulated dose distribution at the time of the second 
PET scan and variations in the FDG uptake. Volumetric maps 
of αeff values within GTVprim, as well as the average 
(a_αeff) and negative fractions (nf_αeff) of αeff values were 
determined. Patients were stratified in responders and non-
responders to treatment based on previously determined 
criteria for overall survival at 2 years for concurrent 
chemoradiotherapy in lung cancer (a_αeff>0.004 Gy-1 and 
nf_αeff≤30%). The spatial distribution of the αeff values was 
mapped for the non-responders to treatment for future 
adaptation strategies. 
 
Results: The previously proposed method was feasible for 
H&N cancer patients and predicted good response in 54% of 
the patients having simultaneously a_αeff>0.004 Gy-1 and 
nf_αeff≤30%. Figure 1a shows an example of the effective 
radiosensitivity map for a selected slice of the GTVprim in 
one of the H&N cancer patients. The corresponding binary 
image with threshold on the negative portion of the αeff 
distribution is presented in Figure 1b (white: αeff>0; black: 
αeff<0). Calculated volumetric maps of the effective 
radiosensitivity values showed that it was possible to segment 
confined sub-regions in the tumour which might indicate 
resistance to the treatment (Figure 1b).  
 
Conclusion: Confined tumour sub-regions showing lack of 
metabolic response which might correlate to resistance to 
treatment could be identified at an early stage during the 
radiotherapy regime. Investigations on different dose 
boosting strategies are on-going to account for the 
quantitative information available from the αeff volumetric 
maps.  
